BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
about
The role of p53 in silica-induced cellular and molecular responses associated with carcinogenesisTreatment of diffuse large B cell lymphomaInhibitor of kappaB kinase beta regulates redox homeostasis by controlling the constitutive levels of glutathioneEffect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of actionPeroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair.Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine.A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.Ehrlichia type IV secretion effector ECH0825 is translocated to mitochondria and curbs ROS and apoptosis by upregulating host MnSODCentral carbon metabolism in the progression of mammary carcinomaUsing biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3(PT) platinum-resistant human ovarian cancer cells.Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma.Transcriptional regulation of human organic anion transporter 1 by B-cell CLL/lymphoma 6.Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells.SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell death.Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta.Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli.Transcriptome analysis of monocyte-HIV interactions.DNA base excision repair and nucleotide excision repair synergistically contribute to survival of stationary-phase cells of the fission yeast Schizosaccharomyces pombe.Caspase activation and apoptosis in response to proteasome inhibitors.ERK and p38 Upregulation versus Bcl-6 Downregulation in Rat Kidney Epithelial Cells Exposed to Prolonged Hypoxia.Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria.
P2860
Q23918080-408652C9-A0DF-4FCA-A593-75E15814F94AQ27006062-60BFB930-1A3C-48D7-82C2-67B656082101Q30475693-ECBEEB15-B8D7-46E5-B6C1-849031CC0C47Q33584645-2F1B8FB3-F19B-4E89-A74C-639DA5BA8F0AQ34624406-E5359CA5-C5B1-47C9-BFAC-B03D548FAA74Q34731608-A7FF487E-3527-4AA1-8A93-04ECE755C349Q34759878-F3589CA0-C1CA-400C-871D-53682303C7AAQ35691202-0E5838F2-DE07-4104-8813-6E89150FBB10Q35930640-2B6A5865-8EFD-4325-8CF4-37B9BB4FCD51Q36020043-A038CAAE-0132-4555-BC72-3557A19B5E5FQ36738269-59086479-448C-4457-8E9E-E8A466E62418Q36776444-406291E8-ABEA-42BA-B6AB-2F3B007E13BDQ37229429-63331EDE-90C9-4ABF-81B8-E409327CA3AAQ38179500-80ECEF56-2F66-4E6F-98F3-B86B3582B971Q38955312-A374FA39-7876-428B-8988-7BD95FB7493AQ39393647-806291AD-8871-461B-9752-49288CD04421Q39986115-2102BB03-72CE-4A31-98A8-10C89644F6B6Q40203788-3E2513DD-D23C-4212-BC5B-DF3F439A2937Q40214079-2AC0B0A6-6E3A-487B-B3C5-B3799DF28D58Q42030451-BAB724E2-3515-437A-A192-4B6D3FB4D5E2Q46439083-92D6F040-DDF1-4083-B9B4-0631EC4FA3C2Q46645046-FEFE653B-4B2C-46E6-854B-AB81DB0BB760Q47108831-7D89B8CE-3DA8-4AD7-9C3F-2A693101AF14Q51075769-CC48E00B-77FB-4EAF-82A7-A1446C87ED84Q52915032-24C9B52F-0B37-4A8B-B103-0023728D9ACF
P2860
BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
BCL6 overexpression prevents i ...... ents in B-cell lymphoma cells.
@en
BCL6 overexpression prevents i ...... ents in B-cell lymphoma cells.
@nl
type
label
BCL6 overexpression prevents i ...... ents in B-cell lymphoma cells.
@en
BCL6 overexpression prevents i ...... ents in B-cell lymphoma cells.
@nl
prefLabel
BCL6 overexpression prevents i ...... ents in B-cell lymphoma cells.
@en
BCL6 overexpression prevents i ...... ents in B-cell lymphoma cells.
@nl
P2093
P2860
P356
P1433
P1476
BCL6 overexpression prevents i ...... ents in B-cell lymphoma cells.
@en
P2093
Osamu Miura
Tetsuya Fukuda
Tetsuya Kurosu
Tohru Miki
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206755
P407
P577
2003-07-01T00:00:00Z